Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa.

Documenti analoghi

• Improved antimicrobial activity of DU-6859a, a new fluoroquinolone, against quinolone-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates with alterations in GyrA and ParC proteins.
  di: Deguchi, T, et al.
  Pubblicazione: (1997)
• The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran
  di: Nouri, Roghayeh, et al.
  Pubblicazione: (2016)
• Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
  di: Ozeki, S, et al.
  Pubblicazione: (1997)
• Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae.
  di: Deguchi, T, et al.
  Pubblicazione: (1997)
• Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam
  di: Nguyen KV, et al.
  Pubblicazione: (2018-02-01)